Strada
The regulatory, legislative, American Medical Association (AMA), Centers for Medicare and Medicaid (CMS), Medical Societies and payer landscapes continue to evolve and change. However, the synergistic fundamentals of successful reimbursement between coding, coverage and payment sustain. This is the strategic foundation upon which Strada was formed with a distinctive approach of aligning client's business and reimbursement goals. Lynn Saccoliti Ms. Saccoliti's commitment to new and emerging medical technology patient access spans over twenty years of medical device reimbursement experience. Her healthcare background also includes an additional ten years in both the private payer and benefits consulting arenas. Leadership Ms. Saccoliti has held several senior medical device company reimbursement positions including Senior Director, Health Economics and Reimbursement at PROCEPT BioRobotics. Her leadership as Senior Director Reimbursement/Government Relations with VidaMed, Inc. resulted in securing a Category l CPT Code, attaining broad private payer and CMS local carrier coverage and securing appropriate hospital outpatient and physician global office payments. As a new urology payment mechanism, VidaMed's physician global office payment was captured in the AdvaMed Outlook For Medical Technology and Innovation Report by the Lewin Group. In 2002 Medtronic acquired VidaMed, Inc. At Medtronic Ms. Saccoliti held the position of Director of Strategic Reimbursement. Extensive payer coverage, new coding and appropriate payments were achieved as Vice President Reimbursement Affairs at Rita Medical Systems. Angiodynamics acquired Rita Medical in 2006. Ms. Saccoliti participates in industry forums such as reimbursement panels, coalitions and Congressional leadership meetings. She is active in the Medical Device Manufacturers Association (MDMA) Reimbursement Workgroup, conducts board and corporate presentations and engages in investor communication. Strada's Professional Network Certified coding Medical Society and Industry leadership CMS and Private Payers Medical Device Companies AMA Legal Health economics |